Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

State Street bullish on growth in 2014

Monday, December 09, 2013

Benedicte Gravrand, Opalesque Geneva:

State Street Global Advisors (SSgA), the asset management business of State Street Corporation highlighted in its global outlook for 2014 five key investment themes, around an expected recovery with some remaining risks.

Globally, the U.S., and to a certain extent Europe will continue in their recovery course. Emerging market will be impacted by a stronger global economy and a strengthening dollar. SSgA expects a 7.5% growth for China. Overall one should still be cautious of the sluggish growth and the normalization of monetary policy.

State Street’s investment themes are:

1. Fixed income in transition, due to diverging monetary policies, the U.S. tapering, and rising rates.

2. Eurozone recovery: expected rallies in peripheral stocks, and UK should be the best G10 performer despite inflationary pressures.

3. Emerging markets: bond and equities offer good upside for 2014, but investors may have to be selective.

4. Overvalued safe havens: government bonds seem to have lost their safe haven appeal, and this extends into other fixed income segments and cash.

5. The changing face of correlations: challenges in 2014 will make it difficult to build well diversified portfolios, so tactical asset allocation may work best. SSgA ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its